Product Information
TERIFLUNOMIDE 7 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.2917 per EA under NDC 31722024630. Its NADAC has been published 118 times since May 22, 2024.
FDA first approved this application on Mar 13, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722024630
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TERIFLUNOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209598FDA Approved
3/13/2023
TE Code
AB
On Market Since
3/13/2023
Pharmacological Classes
Price Statistics
The NADAC for TERIFLUNOMIDE 7 MG TABLET has been published 118 times since May 22, 2024, and over the history we have for it it has declined 51.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2917 per EA |
|---|---|
| All-time high | $0.6572 (Mar 11, 2026) |
| All-time low | $0.2917 (Aug 19, 2026) |
| 52-week high | $0.6572 |
| 52-week low | $0.2917 |
| Median price | $0.5460 |
| Average price | $0.5203 |
| Largest weekly change | -28.7% (May 20, 2026) |
| Weeks tracked | 118 |
| Tracking since | May 22, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TERIFLUNOMIDE 7 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TERIFLUNOMIDE 7 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.2917 per EA (NDC 31722024630), effective Aug 19, 2026.
How has the price of TERIFLUNOMIDE 7 MG TABLET changed over time?
Over the history we have for it, the NADAC for TERIFLUNOMIDE 7 MG TABLET has declined 51.8%. It has been tracked across 118 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for TERIFLUNOMIDE 7 MG TABLET?
Since May 22, 2024, the NADAC for TERIFLUNOMIDE 7 MG TABLET has ranged from a low of $0.2917 (Aug 19, 2026) to a high of $0.6572 (Mar 11, 2026), with a median of $0.5460 per EA.
Are there cheaper alternatives to TERIFLUNOMIDE 7 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TERIFLUNOMIDE 7 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TERIFLUNOMIDE 7 MG TABLET?
TERIFLUNOMIDE 7 MG TABLET (NDC 31722024630) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.